Trial Profile
Pivotal phase IIb/III trial of resminostat in combination with sorafenib as first-line therapy in patients with advanced liver cancer
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 12 Nov 2014
Price :
$35
*
At a glance
- Drugs Resminostat (Primary) ; Sorafenib
- Indications Liver cancer
- Focus Registrational; Therapeutic Use
- 12 Feb 2014 New trial record